News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Praveen Kumar Marimuthu: Five-year overall survival update from the HIMALAYA study
Praveen Kumar Marimuthu/X
Apr 14, 2025, 14:22

Praveen Kumar Marimuthu: Five-year overall survival update from the HIMALAYA study

Praveen Kumar Marimuthu, DM Resident in Medical Oncology at Christian Medical College and Hospital, shared a post on X:

“Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC.”

Praveen Kumar Marimuthu: Five-year overall survival update from the HIMALAYA study

Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC

Authors: Lorenza Rimassa, et al.

Praveen Kumar Marimuthu: Five-year overall survival update from the HIMALAYA study

cancer Christian Medical College and Hospital Durvalumab fight against cancer Global fight against cancer HCC HIMALAYA study MedOnc OncoDaily Oncology Praveen Kumar Marimuthu Tremelimumab
Special Coverage
Blog
May 28, 2025, 07:14
Mandy Davis Aitken Shares ASCO25 Travel Tip: Free Digital Metra Tickets Return
Blog
May 28, 2025, 07:09
Goutham Sunny: Lutetium-177–PSMA-617 or Cabazitaxel in Metastatic Prostate Cancer
Blog
May 28, 2025, 06:14
Mark Tyson Comments on Real-World Outcomes of Intravesical Gemcitabine in BCG-Unresponsive Bladder Cancer
Blog
May 28, 2025, 06:08
ESMO Elections 2025 - Leadership Roles in Education, Policy, and Membership
Blog
May 28, 2025, 06:00
Diego Díaz García Shares OptiTROP-Lung03 Trial Results at ASCO
Blog
May 28, 2025, 05:52
Applications are Open for ESO’s Refresher Course
Blog
May 28, 2025, 05:46
Arndt Vogel: Epidemiology, Pathogenesis, Biology and Evolving Management of MSI-H/dMMR Cancers
Drugs
May 28, 2025, 05:38
Sorafenib (Nexavar): What patients need to know?
Blog
May 28, 2025, 04:13
ASCO25 to Spotlight Evolving Standards in RCC and Urothelial Cancer Care
Insight
May 28, 2025, 03:50
Patrizia Giannatempo: Phase 1/2 Duravelo-1 study
Blog
May 28, 2025, 02:31
Jaume Capdevila: Great discussion on Neuroendocrine Cancer at ASCO25
Blog
May 28, 2025, 00:35
Stephen Chun: Special episode of NRG Oncology on LBA results of BR003 for triple negative breast cancer